Compare Quest Diagnostics Inc (DGX) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs United States Natural Gas Fund — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while United States Natural Gas Fund trades at $10.38. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while United States Natural Gas Fund pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| DGX | UNG | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | Commodities - Energy |
52-Week High | $216.02 | $16.90 |
52-Week Low | $166.42 | $10.15 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
UNG trades at $10.37, down 2.17% today, with a bearish technical signal from moving averages. The fund tracks natural gas futures, facing headwinds from contango effects and weather-dependent demand. Recent news highlights volatility tied to LNG exports and storage data, with EIA forecasting record 2026 supply and demand (Reuters, 2026-06-09).
Outlook remains cautious due to structural challenges in futures roll costs and price sensitivity to weather. Risks include production swings and geopolitical factors, while opportunities hinge on sustained LNG demand growth. Long-term performance has been hampered by contango, as noted by 24/7 Wall Street (2026-05-28).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
